American Pharmacists Association (APhA)
FDANonrulemakingFDA-2026-N-3962

Vaccines and Related Biological Products Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments – United States (U.S.) 2026-2027 Formula for COVID-19 Vaccine Composition.

RIN
Last modified
May 29, 2026
Comment window
closed 62d ago
American Pharmacists Association (APhA) filings
1

Activity

American Pharmacists Association (APhA) filed 1 comment on this docket between May 29, 2026 and May 29, 2026. 0 other organizations filed here. The comment window closed 62d ago.

What American Pharmacists Association (APhA) filed (1)

May 29, 2026· Comment from American Pharmacists Association· FDA-2026-N-3962-0102

Dear Vaccines for Related Biological Products Advisory Committee, The American Pharmacists Association (APhA) appreciates the opportunity to provide the Vaccines for Related Biological Products Advisory Committee (VRBPAC) with comments on the essential role pharmacists play in administering COVID-19 vaccines and keeping patients healthy. APhA represents pharmacists, student pharmacists, and pharmacy technicians in all practice settings, including but not limited to community pharmacies, hospitals, long-term care facilities, specialty pharmacies, community health centers, physician offices, ambulatory clinics, managed care organizations, hospice settings, and government facilities. Our members strive to improve medication use, advance patient care, and enhance public health. Full comments are attached.

Abstract

No abstract recorded.

View on regulations.gov →
Vaccines and Related Biological Products Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments – United States (U.S.) 2026-2027 Formula for COVID-19 Vaccine Composition. (FDA) — American Pharmacists Association (APhA) | OpenPolis